Different Flu Vaccines for the treatment of coming seasonal flu
Released on = October 3, 2006, 5:17 am
Press Release Author = Benzer Pharmaceuticals Pvt. Ltd.
Industry = Pharmaceuticals
Press Release Summary = Flu medications such as Relenza and tamiflu become essential
when the seasonal flu attacks and spreads fast among children and adults.
Press Release Body = When the season of flu arrives, it becomes necessary to go for
a flu vaccination. Flu vaccines help fights the human immune system to recognize and
attack specific flu viruses and because of the fact that viruses changes very fast,
yearly vaccination becomes essential.
Each year flu viruses are being traced by the medical professionals that could
circulate during the seasonal flu and then it is decided to go for certain flu
vaccination. Oral antiviral drugs such as Rimantadine (Flumadine) and newer agents
Tamiflu and Relenza appear to work to prevent flu viruses.
According to sources, the manufacturer of the prescription medication Tamiflu has
declared that there will be ample supply of the medicine for the year 2006-2007 all
across the U.S. pharmacies. This is going to be double the quantity held last year.
On this occasion, the president and CEO of the company said "Physicians can be
confident that Tamiflu will be readily and widely available to patients who need it
for flu treatment and post-exposure prevention."
At the same time, manufacturer of the antiviral influenza treatment Zanamivir
(active ingredient in Relenza ®) has made an agreement with other pharmaceutical
companies in other parts of the world to manufacture and sell the product. This has
been done to expand available supplies of zanamivir in areas of the world that may
be on the front line of a possible influenza pandemic.
Relenza is therefore approved in many markets for the effective treatment of
Influenza A and B among children and adults as well as for prophylaxis.
Please do visit http://www.benzer11.com/relenza.html to know more about influenza
flu medicines and approved treatments.
2025
